JOLINE BROTZMAN: Open Payments
NPI 1578813606 · FOND DU LAC, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 14 payments from 8 companies in 2025. Trend: 2023 $478 · 2024 $337 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $96 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Indivior Inc. | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $15 |
Products named: REXULTI, ARISTADA, COBENFY, SUBLOCADE, Auvelity, CAPLYTA, VIVITROL, TRINTELLIX.
Industry payments across WI — which companies pay providers there.
